135 related articles for article (PubMed ID: 23435675)
21. Characterization of anti-advanced glycation end product antibodies to nonenzymatically lysine-derived and arginine-derived glycated products.
Choi YG; Lim S
J Immunoassay Immunochem; 2009; 30(4):386-99. PubMed ID: 19739013
[TBL] [Abstract][Full Text] [Related]
22. Novel application of surface plasmon resonance biosensor chips for measurement of advanced glycation end products in serum of Zucker diabetic fatty rats.
Kim YS; Yi SY; Kim J; Kim M; Kim CS; Chung BH; Kim JS
Biosens Bioelectron; 2009 Sep; 25(1):248-52. PubMed ID: 19589671
[TBL] [Abstract][Full Text] [Related]
23. Influence of Maillard products from bread crust on magnesium bioavailability in rats.
Roncero-Ramos I; Delgado-Andrade C; Morales FJ; Navarro MP
J Sci Food Agric; 2013 Jun; 93(8):2002-7. PubMed ID: 23254393
[TBL] [Abstract][Full Text] [Related]
24. Dietary intake associated with serum versus urinary carboxymethyl-lysine, a major advanced glycation end product, in adults: the Energetics Study.
Semba RD; Ang A; Talegawkar S; Crasto C; Dalal M; Jardack P; Traber MG; Ferrucci L; Arab L
Eur J Clin Nutr; 2012 Jan; 66(1):3-9. PubMed ID: 21792213
[TBL] [Abstract][Full Text] [Related]
25. Graded sensitiveness of the various retinal neuron populations on the glyoxal-mediated formation of advanced glycation end products and ways of protection.
Reber F; Geffarth R; Kasper M; Reichenbach A; Schleicher ED; Siegner A; Funk RH
Graefes Arch Clin Exp Ophthalmol; 2003 Mar; 241(3):213-25. PubMed ID: 12644946
[TBL] [Abstract][Full Text] [Related]
26. Temporal increases in urinary carboxymethyllysine correlate with albuminuria development in diabetes.
Coughlan MT; Forbes JM
Am J Nephrol; 2011; 34(1):9-17. PubMed ID: 21654162
[TBL] [Abstract][Full Text] [Related]
27. Nepsilon-(carboxymethyl)lysine, Nepsilon-(carboxyethyl)lysine and vascular cell adhesion molecule-1 (VCAM-1) in relation to peritoneal glucose prescription and residual renal function; a study in peritoneal dialysis patients.
van de Kerkhof J; Schalkwijk CG; Konings CJ; Cheriex EC; van der Sande FM; Scheffer PG; ter Wee PM; Leunissen KM; Kooman JP
Nephrol Dial Transplant; 2004 Apr; 19(4):910-6. PubMed ID: 15031349
[TBL] [Abstract][Full Text] [Related]
28. Plasma sRAGE and N-(carboxymethyl) lysine in patients with CHF and/or COPD.
Boschetto P; Campo I; Stendardo M; Casimirri E; Tinelli C; Gorrini M; Ceconi C; Fucili A; Potena A; Papi A; Ballerin L; Fabbri LM; Luisetti M
Eur J Clin Invest; 2013 Jun; 43(6):562-9. PubMed ID: 23590548
[TBL] [Abstract][Full Text] [Related]
29. Assessment of the concentrations of various advanced glycation end-products in beverages and foods that are commonly consumed in Japan.
Takeuchi M; Takino J; Furuno S; Shirai H; Kawakami M; Muramatsu M; Kobayashi Y; Yamagishi S
PLoS One; 2015; 10(3):e0118652. PubMed ID: 25730321
[TBL] [Abstract][Full Text] [Related]
30. Detection of N epsilon-(carboxymethyl)lysine (CML) and non-CML advanced glycation end-products in the anterior horn of amyotrophic lateral sclerosis spinal cord.
Kikuchi S; Shinpo K; Ogata A; Tsuji S; Takeuchi M; Makita Z; Tashiro K
Amyotroph Lateral Scler Other Motor Neuron Disord; 2002 Jun; 3(2):63-8. PubMed ID: 12215227
[TBL] [Abstract][Full Text] [Related]
31. N epsilon-(carboxymethyl)lysine during the early development of hypertension.
Baumann M; Stehouwer C; Scheijen J; Heemann U; Struijker Boudier H; Schalkwijk C
Ann N Y Acad Sci; 2008 Apr; 1126():201-4. PubMed ID: 18079484
[TBL] [Abstract][Full Text] [Related]
32. Clinical and prognostic value of advanced glycation end-products in chronic heart failure.
Hartog JW; Voors AA; Schalkwijk CG; Scheijen J; Smilde TD; Damman K; Bakker SJ; Smit AJ; van Veldhuisen DJ
Eur Heart J; 2007 Dec; 28(23):2879-85. PubMed ID: 17986469
[TBL] [Abstract][Full Text] [Related]
33. Detection of elevated N epsilon-carboxymethyllysine levels in muscular tissue and in serum of patients with fibromyalgia.
Rüster M; Franke S; Späth M; Pongratz DE; Stein G; Hein GE
Scand J Rheumatol; 2005; 34(6):460-3. PubMed ID: 16393769
[TBL] [Abstract][Full Text] [Related]
34. Determination of N epsilon-(carboxymethyl)lysine in foods and related systems.
Ames JM
Ann N Y Acad Sci; 2008 Apr; 1126():20-4. PubMed ID: 18448791
[TBL] [Abstract][Full Text] [Related]
35. Dose-dependent utilisation of casein-linked lysinoalanine, N(epsilon)-fructoselysine and N(epsilon)-carboxymethyllysine in rats.
Somoza V; Wenzel E; Weiss C; Clawin-Rädecker I; Grübel N; Erbersdobler HF
Mol Nutr Food Res; 2006 Sep; 50(9):833-41. PubMed ID: 16917812
[TBL] [Abstract][Full Text] [Related]
36. Plasma advanced glycation end products are decreased in obese children compared with lean controls.
Sebeková K; Somoza V; Jarcusková M; Heidland A; Podracká L
Int J Pediatr Obes; 2009; 4(2):112-8. PubMed ID: 18645732
[TBL] [Abstract][Full Text] [Related]
37. Hypochlorous acid generates N epsilon-(carboxymethyl)lysine from Amadori products.
Mera K; Nagai R; Haraguchi N; Fujiwara Y; Araki T; Sakata N; Otagiri M
Free Radic Res; 2007 Jun; 41(6):713-8. PubMed ID: 17516244
[TBL] [Abstract][Full Text] [Related]
38. Antioxidant balance after long-term consumption of standard diets including bread crust glycated compounds by adult rats.
Pastoriza S; Roncero-Ramos I; Rufián-Henares JÁ; Delgado-Andrade C
Food Res Int; 2014 Oct; 64():106-113. PubMed ID: 30011629
[TBL] [Abstract][Full Text] [Related]
39. The advanced glycation end product N(epsilon)-carboxymethyllysine is not a predictor of cardiovascular events and renal outcomes in patients with type 2 diabetic kidney disease and hypertension.
Busch M; Franke S; Wolf G; Brandstädt A; Ott U; Gerth J; Hunsicker LG; Stein G;
Am J Kidney Dis; 2006 Oct; 48(4):571-9. PubMed ID: 16997053
[TBL] [Abstract][Full Text] [Related]
40. N(ɛ)-(carboxymethyl)lysine linkage to α-synuclein and involvement of advanced glycation end products in α-synuclein deposits in an MPTP-intoxicated mouse model.
Choi YG; Lim S
Biochimie; 2010 Oct; 92(10):1379-86. PubMed ID: 20624443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
